CVS Health shows strong growth with strategic shifts, improved Medicare ratings, and promising earnings. Read why I see CVS ...

The stock's fall snapped a two-day winning streak.

"Investors are piling into these two because their top competitors are falling apart, leaving CVS and Dollar General as the last men standing in their respective industries." Cramer reviewed ...

CVS Health Corp.’s drug-benefits unit negotiated a deal to make Novo Nordisk A/S’s Wegovy more widely available to its ...

CVS Express keeps competition with Walgreens strong, and contends with the latter’s in-store pickup program but takes it another step further with curbside delivery. CVS features The drugstore ...

to the exclusion of competitor Eli Lilly's (LLY) Zepbound, for $499 per month. "Now that there's adequate supply of both of these GLP-1s, CVS Caremark was able to negotiate Wegovy against Zepbound ...

This was the stock's third consecutive day of losses.